S01LA Antineovascularisation agents Antineovascularisation agents 抗血-视网膜屏障破坏试剂 抗血-視網膜屏障破壞試劑 L4
Source: Wikipedia · CC BY-SA 4.0 Fuente: Wikipedia · CC BY-SA 4.0 · nombre de respaldo (en) 来源:维基百科 · CC BY-SA 4.0 來源:維基百科(中文轉繁體) · CC BY-SA 4.0 (derived zh-Hant)
ATC level L4 · Search this class · Consumer categories
Active ingredients in this class
10 active ingredients 10 principios activos 10 个活性成分 10 個有效成分
Each market now shows one aggregated status: a market counts as on sale if it has any active record; individual record statuses are shown in the details. The same market can also have several registration records with different statuses, so each market appears only once here; that is a record fact, not a safety judgement.
A missing name is marked in its row only when it is the exception; when most names lack it, the list stays unmarked.
- Faricimab
S01LA09active US GB CA AU SG · and 8 more y 8 más 另有 8 个 另有 8 個
active US GB CA AU SG CN ES MX TW EU FR · unknown HK - Aflibercept
S01LA05active US GB CA AU SG · and 7 more y 7 más 另有 7 个 另有 7 個
active US GB CA AU SG ES MX TW EU FR · unknown HK - Ranibizumab
S01LA04active US GB CA AU SG · and 7 more y 7 más 另有 7 个 另有 7 個
active US GB CA AU SG ES MX TW EU FR · unknown HK - Brolucizumab
S01LA06active US GB CA AU ES · and 6 more y 6 más 另有 6 个 另有 6 個
active US GB CA AU ES MX TW EU FR · unknown HK - Verteporfin
S01LA01active US GB CA SG ES · and 5 more y 5 más 另有 5 个 另有 5 個
active US GB CA SG ES TW EU FR · unknown HK - Pegaptanib
S01LA03active GB · and 4 more y 4 más 另有 4 个 另有 4 個
active GB · discontinued CA · withdrawn EU - 雷珠单抗
S01LAactive CN
active CN - 康柏西普眼用
S01LAactive CN
active CN - 阿柏西普眼内注射
S01LAactive CN
active CN - 维替泊芬
S01LAactive CN
active CN
By dosage form, across markets
Only ingredients with a recorded ATC class are listed (6,009 of 12,637).